| Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology … GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and haemostasis 120 (12), 1597-1628, 2020 | 186 | 2020 |
| A review on thromboangiitis obliterans pathophysiology: thrombosis and angiitis, which is to blame? B Fazeli, SA Rezaee Vascular 19 (3), 141-153, 2011 | 68 | 2011 |
| Tissue plasminogen activator in nervous system function and dysfunction S Strickland Thrombosis and haemostasis 86 (07), 138-143, 2001 | 66 | 2001 |
| How to treat a patient with thromboangiitis obliterans: a systematic review B Fazeli, MD Moghadam, S Niroumand Annals of vascular surgery 49, 219-228, 2018 | 51 | 2018 |
| Thrombophlebitis migrans as a footprint of Buerger’s disease: a prospective–descriptive study in north-east of Iran B Fazeli, H Modaghegh, H Ravrai, G Kazemzadeh Clinical rheumatology 27, 55-57, 2008 | 35 | 2008 |
| Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients A Mohammadi, B Fazeli, M Taheri, A Sahebkar, Z Poursina, V Vakili, ... Biomedicine & Pharmacotherapy 85, 457-462, 2017 | 34 | 2017 |
| Triple therapy with prednisolone, pegylated interferon and sodium valproate improves clinical outcome and reduces human T-cell leukemia virus type 1 (HTLV-1) proviral load, tax … R Boostani, R Vakili, SS Hosseiny, A Shoeibi, B Fazeli, MM Etemadi, ... Neurotherapeutics 12 (4), 887-895, 2015 | 31 | 2015 |
| Buerger’s disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of Iran B Fazeli Archives of Medical Science 6 (3), 343-347, 2010 | 30 | 2010 |
| The imbalance among oxidative biomarkers and antioxidant defense systems in thromboangiitis obliterans (Winiwarter-Buerger Disease) H Sharebiani, B Fazeli, R Maniscalco, D Ligi, F Mannello Journal of Clinical Medicine 9 (4), 1036, 2020 | 27 | 2020 |
| The COVID-19 pandemic and the need for an integrated and equitable approach: an international expert consensus paper GT Gerotziafas, M Catalano, Y Theodorou, P Van Dreden, V Marechal, ... Thrombosis and Haemostasis 121 (08), 992-1007, 2021 | 25 | 2021 |
| Visceral bed involvement in thromboangiitis obliterans: a systematic review F Fakour, B Fazeli Vascular health and risk management, 317-353, 2019 | 23 | 2019 |
| Sera of patients with thromboangiitis obliterans activated cultured human umbilical vein endothelial cells (HUVEC s) and changed their adhesive properties B Fazeli, H Rafatpanah, H Ravari, R Farid Hosseini, J Tavakol Afshari, ... International journal of rheumatic diseases 17 (1), 106-112, 2014 | 23 | 2014 |
| Recent updates and advances in Winiwarter-Buerger disease (thromboangiitis obliterans): biomolecular mechanisms, diagnostics and clinical consequences B Fazeli, D Ligi, S Keramat, R Maniscalco, H Sharebiani, F Mannello Diagnostics 11 (10), 1736, 2021 | 22 | 2021 |
| Mechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliterans B Fazeli, H Ravari Current medicinal chemistry 22 (16), 1992-2001, 2015 | 22 | 2015 |
| Investigation of the expression of mediators of neovascularization from mononuclear leukocytes in thromboangiitis obliterans B Fazeli, H Rafatpanah, H Ravari, RF Hosseini, SAR Rezaee Vascular 22 (3), 174-180, 2014 | 21 | 2014 |
| Thromboangiitis obliterans episode: autoimmune flare-up or reinfection? M Mohareri, A Mirhosseini, S Mehraban, B Fazeli Vascular Health and Risk Management, 247-251, 2018 | 20 | 2018 |
| Natural history definition and a suggested clinical approach to Buerger's disease: a case-control study with survival analysis B Fazeli, H Ravari, R Assadi Vascular 20 (4), 198-202, 2012 | 19 | 2012 |
| Management of Buerger's disease in endovascular era BM Ghoneim, AG Karmota, AM Abuhadema, AA Shaker, HM Abdelmawla, ... International Journal of Angiology 28 (03), 173-181, 2019 | 16 | 2019 |
| Does a species of Rickettsia play a role in the pathophysiology of Buerger's disease? B Fazeli, H Ravari, M Farzadnia Vascular 20 (6), 334-336, 2012 | 16 | 2012 |
| Oxidative and antioxidative pathways might contribute to thromboangiitis obliterans pathophysiology DH Alamdari, H Ravari, S Tavallaie, B Fazeli Vascular 22 (1), 46-50, 2014 | 13 | 2014 |
Hassan RavariProfessor of Vascular surgery , Mashhad University of Medical SciencesVerified email at mums.ac.ir
